Composition, kit and detection method for detecting urinary tract infection pathogens
Through real-time fluorescence quantitative PCR technology, the detection composition of specific primers and probes is designed, which solves the false negative and low detection rate of existing urinary tract infection diagnosis methods, and achieves early high sensitivity and specificity for urinary tract infection pathogens , which improves the detection efficiency and precision, and enhances the ability to prevent urinary tract infection complications and antibiotic resistance.
Patent Information
- Application Number
- CN202411095598.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-09
- Publication Date
- 2024-11-08
AI Technical Summary
The existing standard diagnostic methods for urinary tract infection are prone to false negatives, time-consuming and contaminated, and the detection rates of B.C. and Providentii are underestimated due to misidentification, making it difficult to detect and distinguish early, resulting in urine. The development of road infection complications and antibiotic resistance is difficult to prevent.
Using real-time fluorescence quantitative PCR technology, by designing specific upstream and downstream primers and probes, it provides a composition for detecting urinary tract infection pathogens, which can accurately and quickly detect and distinguish between B. urea, B. urea, B. urea, B. green, and S. Providencial and Provendocrine Reynolds improve detection efficiency and precision, realize joint inspection and distinction, and avoid non-specific amplification.
Early high sensitivity, specificity and precision detection of urinary tract infection pathogens has been achieved, detection efficiency has been improved, detection cycle has been shortened, and prevention ability to urinary tract infection complications and antibiotic resistance has been enhanced.
Smart Images

Figure CN118910295A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and in particular relates to a composition, a kit and a detection method for detecting pathogens of urinary tract infection. Background Art
[0002] Aerococcus is a gram-positive bacteria in the Aerococcaceae family, including 8 species. It is widely found in the air, soil, plants, and medical environments. It is a potential pathogen of opportunistic infections and can cause urinary tract infections, bloodstream infections, endocarditis, bone and joint infections, soft tissue infections, meningitis, peritonitis, abscesses, etc., and even cause serious drug resistance and are difficult to cure. A large number of reports have shown that Aerococcus strains can cause urinary tract infections in clinical patients, and most of them are elderly women with basic urinary tract disorders. The detection of some asymptomatic patients suggests that this genus may have a certain degree of colonization and can cause infection in patients under certain conditions. It is currently underestimated due to the lack of biochemical and other identification techniques.
[0003] Providencia is a urease-producing Gram-negative bacillus in the Enterobacteriaceae family, which includes 5 species. It not only causes discomfort and pain to patients, but can also lead to serious complications such as pyelonephritis, sepsis, and chronic kidney disease, and can also cause recurrent, complicated urinary tract infections. They often even show resistance to multiple antibiotics, and sometimes cause serious complications such as bacteremia or systemic diseases.
[0004] The standard diagnostic methods for urinary tract infection, mainly urinalysis and culture, are often limited by their susceptibility to false negatives under various conditions, such as low bacterial counts, recent antibiotic use, or dilute urine. In addition, although cultures are informative, they are time-consuming and prone to contamination, and often fail to detect the pathogen. The detection rate of this genus has been underestimated due to historical misidentification, resulting in low clinical attention to this genus. Summary of the invention
[0005] In order to solve the above-mentioned problems in the prior art, the object of the present invention is to provide a composition, a kit and a detection method for detecting pathogens of urinary tract infection.
[0006] The present invention provides a composition for detecting urinary tract infection pathogens, the composition comprising at least one of component A, component B, component C, component D, and component E;
[0007] The component A comprises: a primer pair of SEQ ID NOs: 1 to 2, and a probe of SEQ ID NO: 3; the component A detects Ureaplasma;
[0008] The component B comprises: a primer pair of SEQ ID NOs: 4 to 5, and a probe of SEQ ID NO: 6; the component B detects blood balloon bacteria;
[0009] The component C comprises: a primer pair of SEQ ID NOs: 7 to 8, and a probe of SEQ ID NO: 9; the component C detects green balloon fungi;
[0010] The component D comprises: a primer pair of SEQ ID NOs: 10 to 11, and a probe of SEQ ID NO: 12; the component D detects Providencia stuartii;
[0011] The component E comprises: a primer pair of SEQ ID NOs: 13-14, and a probe of SEQ ID NO: 15; the component E detects Providencia rettgeri.
[0012] The present invention adopts real-time fluorescence quantitative PCR technology. Through the careful design of upstream primers, downstream primers and corresponding probes for detecting various urinary tract infection pathogens, the provided composition for detecting urinary tract infection pathogens can detect and distinguish at least one of Urea Balloon, Sanguinea Balloon, Green Balloon, Providencia stuartii and Providencia rettgeri. It is more suitable for early detection, has high sensitivity, specificity and precision, can accurately and quickly detect Urea Balloon, Sanguinea Balloon, Green Balloon, Providencia stuartii and Providencia rettgeri, improves detection efficiency and shortens detection cycle, which is very important for preventing complications of urinary tract infection and the development of antibiotic resistance.
[0013] Preferably, the composition comprises the component A, the component B, the component C, the component D and the component E.
[0014] The composition described in this scheme includes component A, component B, component C, component D and component E, which can simultaneously realize the joint detection and differentiation of urea balloon bacteria, sanguinea balloon bacteria, green balloon bacteria, Providencia stuartii and Providencia rettgeri, without non-specific amplification, and the overall detection effect is good.
[0015] Preferably, the probes in the component A, the component B, the component C, the component D and the component E are all labeled with fluorescent reporter groups, which are different from each other and do not interfere with each other.
[0016] Preferably, the fluorescent reporter group includes one of FAM, HEX, ROX, CY5 or Quasar 705.
[0017] Preferably, the components of the composition are present in a mixed form.
[0018] The present invention provides a kit for detecting pathogens of urinary tract infection, wherein the kit comprises the composition for detecting pathogens of urinary tract infection.
[0019] Preferably, in each reaction system, the concentration of each primer pair is 0.05 μM to 1 μM, and the concentration of each probe is 0.05 μM to 1 μM.
[0020] Further preferably, in each reaction system, the concentration of each primer pair is 0.2 μM, and the concentration of each probe is 0.1 μM.
[0021] Preferably, the kit further comprises a nucleic acid release reagent, a nucleic acid extraction reagent, a DNA polymerase, a UNG enzyme, a ribonuclease inhibitor, dNTP(U)s, a PCR buffer and Mg 2+ At least one of .
[0022] Preferably, in each reaction system, the concentration of the DNA polymerase is 0.1U / μL to 1U / μL, Mg 2+ The concentration of is 1mM~25mM, and the concentration of dNTP(U)s is 0.02mM~1mM.
[0023] Further preferably, in each reaction system, the concentration of the DNA polymerase is 0.18 U / μL, Mg 2+ The concentration of is 4 mM and the concentration of dNTP(U)s is 0.1 mM.
[0024] Preferably, the kit for detecting urinary tract infection pathogens also includes at least one of a positive quality control product and a negative quality control product.
[0025] The present invention also provides a method for detecting urinary tract infection pathogens for non-diagnostic purposes, characterized in that it comprises the following steps:
[0026] S1. Extracting nucleic acid from a sample to be tested to obtain a nucleic acid sample;
[0027] S2, using the kit for detecting urinary tract infection pathogens to perform PCR amplification on the nucleic acid sample;
[0028] S3. Obtain and analyze the results. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 This is the amplification curve of the joint test of Ureaplasma, Sanguinis, Viridans, Providencia stuartii and Providencia rettgeri in Example 1.
[0030] Figure 2 This is the amplification curve of Example 2 when the concentration of Ureaplasma urea was 500 copies / mL.
[0031] Figure 3 This is the amplification curve of Example 2 when the concentration of blood balloon bacteria is 500 copies / mL.
[0032] Figure 4 This is the amplification curve of Example 2 when the concentration of green balloon bacteria is 500 copies / mL.
[0033] Figure 5 This is the amplification curve of Example 2 when the concentration of Providencia stuartii is 500 copies / mL.
[0034] Figure 6 This is the amplification curve of Example 2 when the concentration of Providencia rettgeri is detected alone at 500 copies / mL.
[0035] Figure 7 This is a specific detection diagram of the PCR reaction system in Example 3.
[0036] Figure 8 This is the amplification curve diagram of the precision detection of Ureaplasma urea under the condition of medium concentration (10000 copies / mL) positive sample in Example 4.
[0037] Fig. 9 This is the amplification curve diagram of the precision detection of blood balloon bacteria under the condition of medium concentration (10000 copies / mL) positive sample in Example 4.
[0038] Fig.10 This is the precision detection amplification curve of Example 4 for green balloon bacteria under the condition of medium concentration (10000 copies / mL) positive sample.
[0039] Fig.11 This is a precision detection amplification curve of Example 4 for Providencia stuartii under medium concentration (10,000 copies / mL) positive sample conditions.
[0040] Fig.12 This is a precision detection amplification curve of Example 4 for Providencia rettgeri under medium concentration (10,000 copies / mL) positive sample conditions.
[0041] Fig.13 The amplification curves are shown for detecting Ureaplasma urea using the primers and probes (SEQ ID NOs: 1-3) in Example 1 and the primers and probes (SEQ ID NOs: 16-18) in Comparative Example 1, respectively.
[0042] Fig.14 This is the amplification curve diagram of the joint test of Ureaplasma, Sanguinis, Vibrio, Providencia stuartii and Providencia rettgeri in Comparative Example 1. DETAILED DESCRIPTION
[0043] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only embodiments of a part of the present invention, rather than all embodiments.
[0044] Example 1
[0045] 1. Reagent preparation
[0046] The real-time fluorescence PCR reaction system (joint detection of Ureaplasma urea, Ureaplasma sanguinis, Ureaplasma viride, Providencia stuartii and Providencia rettgeri) is shown in Table 1. The sequences of the corresponding upstream primers, downstream primers and probes in the real-time fluorescence PCR reaction system are shown in Table 2. The upstream primers, downstream primers and probes provided in Table 2 are the composition for detecting urinary tract infection pathogens provided in this embodiment.
[0047] Table 1 Real-time fluorescence PCR reaction system
[0048] Components The volume of each reaction PCR Buffer 37μL UNG enzyme 0.2μL Taq enzyme (5U / μL) 1.8μL <![CDATA[Mg 2+ (1M)]]> 0.2μL dNTP(U)(0.7mM) 0.5μL Each primer pair (50 μM) 0.2μL Each probe (50 μM) 0.1μL Samples to be tested 10μL
[0049] Table 2 Primer probe sequences
[0050]
[0051]
[0052] The samples to be tested were DNA samples of the experimental group, positive control (mixed plasmids containing Ureaplasma urea target sequence, Bacillus sanguinis target sequence, Bacillus viride target sequence, Providencia stuartii target sequence and Providencia rettgeri target sequence), and negative control (sterile saline). According to Table 1, 40 μL of real-time fluorescence PCR reaction system mixed solution was prepared except for 10 μL of the sample to be tested, and the mixture was centrifuged at 2000 rpm for 10 s and then set aside.
[0053] Different fluorescent reporter groups were used to label different probes for Urea Balloon, Blood Balloon, Green Balloon, Providencia stuartii, and Providencia rettgeri to distinguish signals. Among them, the fluorescent reporter gene of the probe for detecting Urea Balloon is FAM; the fluorescent reporter group of the probe for detecting Blood Balloon is HEX; the fluorescent reporter group of the probe for detecting Green Balloon is ROX; the fluorescent reporter group of the probe for detecting Providencia stuartii is CY5; and the fluorescent reporter group for detecting Providencia rettgeri is Quasar 705.
[0054] 2. Sample processing and sample addition
[0055] Take 300 μL of the experimental group DNA samples, negative controls, and positive controls respectively into 1.5 mL centrifuge tubes, and use the nucleic acid extraction or purification reagent of Shengxiang Biotechnology Co., Ltd. to extract nucleic acid according to its instructions; take 10 μL of the above-treated experimental group DNA samples, negative controls, and positive controls and add them to the corresponding 0.2 mL PCR reaction tubes, add 40 μL of the real-time fluorescence PCR reaction system mixture configured according to Table 1 except 10 μL of the sample to be tested to each tube, and cover the tube cap.
[0056] 3. PCR amplification
[0057] PCR amplification was performed on a Macrostone fluorescent quantitative PCR instrument according to the temperature and time settings shown in Table 3.
[0058] Table 3 Amplification procedures
[0059]
[0060] 4. Detection
[0061] (1) Judgment criteria
[0062] Quality control negative control: FAM, HEX, ROX, CY5 and Quasar 705 channels Ct>40 or no Ct value (NoCt); positive control: FAM, HEX, ROX, CY5 and Quasar 705 channels Ct≤35;
[0063] The above requirements must be met simultaneously in the same experiment, otherwise, the experiment will be invalid and must be repeated.
[0064] Table 4 Judgment criteria
[0065]
[0066] (2) Test results
[0067] The results of the joint test of Example 1 on Urea Balloon, Blood Balloon, Green Balloon, Providencia stuartii and Providencia rettgeri are as follows Figure 1 shown.
[0068] Figure 1 This is the amplification curve of the joint test of Ureaplasma, Sanguinis, Viridans, Providencia stuartii and Providencia rettgeri in Example 1. Figure 1It can be seen that in Example 1, Urea Balloon, Blood Balloon, Green Balloon, Providencia stuartii and Providencia rettgere were jointly tested, and the amplification curves of each urinary tract infection pathogen showed a typical "S-type", among which the Ct value of Urea Balloon was 27.21, the Ct value of Blood Balloon was 25.33, the Ct value of Green Balloon was 27.01, the Ct value of Providencia stuartii was 27.20, and the Ct value of Providencia rettgere was 26.87, and the Ct values were all less than 40, that is, the above-mentioned urinary tract infection pathogens were all detected as positive, and the fluorescence increment of each urinary tract infection pathogen was high, which can realize the detection and differentiation of Urea Balloon, Blood Balloon, Green Balloon, Providencia stuartii and Providencia rettgere, and the upstream primers, downstream primers and corresponding probes corresponding to each urinary tract infection pathogen have little mutual influence.
[0069] Example 2
[0070] Sensitivity test
[0071] Using the real-time fluorescence PCR reaction system in Example 1 of the present invention, and using the primer probe sequences and fluorescent reporter groups corresponding to Urea Balloon, Blood Balloon, Green Balloon, Providencia stuartii, and Providencia rettgeri in Table 2, respectively, the LOD (sensitivity) detection of each urinary tract infection pathogen (Urea Balloon, Blood Balloon, Green Balloon, Providencia stuartii, Providencia rettgeri) target was performed according to the detection method in Example 1, and the concentrations were 1000 copies / mL, 800 copies / mL, 500 copies / mL, and 200 copies / mL, respectively, to simulate clinical samples, and PCR detection was repeated 20 times in parallel on a Hongshi real-time fluorescence quantitative PCR instrument. The results are as follows. Figures 2 to 6 As shown, the results show that each channel can still accurately detect samples as low as 500 copies / mL, with a detection rate (detection rate = number of detections / number of detections) of 100%, indicating that the sensitivity of using the composition for detecting urinary tract infection pathogens of the present invention to detect Urea Balloon, Sanguinea Balloon, Green Balloon, Providencia stuartii, and Providencia rettgeri is 500 copies / mL.
[0072] Example 3
[0073] Specificity test
[0074] Using the real-time fluorescence PCR reaction system in Example 1 of the present invention, and using the primer probe sequences and fluorescent reporter groups corresponding to Ureaplasma urea, Bacillus sanguineus, Vibrio viridans, Providencia stuartii and Providencia rettgeri in Table 2, according to the detection method in Example 1, other common urinary tract pathogens and other pathogens with similar infection symptoms, including Enterococcus faecium (10000 copies / mL), Enterococcus faecalis (10000 copies / mL), Group B Streptococcus (10000 copies / mL), Group A Streptococcus (10000 copies / mL), Pseudomonas aeruginosa (10000 copies / mL), and Enterococcus faecium (10000 copies / mL), respectively. mL), Acinetobacter baumannii (10000 copies / mL), Candida albicans (10000 copies / mL), Ureaplasma urealyticum (10000 copies / mL), Staphylococcus aureus (10000 copies / mL), Staphylococcus saprophyticus (10000 copies / mL), Mycoplasma genitalium (10000 copies / mL) and Trichomonas vaginalis (10000 copies / mL) were used for detection. The composition for detecting urinary tract infection pathogens in this embodiment (primer probe sequences in Table 2) had no cross-reaction with the above-mentioned other common urinary tract pathogens and other pathogens with similar infection symptoms. The detection results of each other common urinary tract pathogen and other pathogens with similar infection symptoms were as follows. Figure 7 As shown, the results show that the use of the composition for detecting pathogens of urinary tract infection of the present invention to detect urea aerosol, sanguinis aerosol, green aerosol, Providencia stuartii and Providencia rettgeri has no non-specific amplification of other common urinary tract pathogens and other pathogens with similar infection symptoms, and has high specificity. This shows that the composition for detecting pathogens of urinary tract infection provided by the present invention has good specificity.
[0075] Example 4
[0076] Precision testing
[0077] Using the real-time fluorescent PCR reaction system in Example 1 of the present invention, and using the primer probe sequences and fluorescent reporter groups corresponding to Urea Balloon, Sanguinea Balloon, Green Balloon, Providencia stuartii, and Providencia rettgeri in Table 2, the positive samples were diluted to a medium concentration (10,000 copies / mL) for precision determination according to the detection method in Example 1, and each sample was measured 10 times. The results are shown in FIG. Figure 8-12 As shown, the detection rates of these samples (detection rate = number of detections / number of tests) were all 100%, and the coefficient of variation (CV) of the Ct value was less than 5%. It can be considered that the composition for detecting urinary tract infection pathogens provided by the present invention has good detection precision.
[0078] Comparative Example 1
[0079] This comparative example refers to Example 1 to detect urinary tract infection pathogens (Urea Balloon, Sanguinea Balloon, Green Balloon, Providencia stuartii and Providencia rettgeri). The difference between this comparative example and Example 1 is that the primer probe sequence for detecting Urea Balloon is different. In addition to the above differences, the other materials and process operations used in this comparative example are strictly consistent with those in Example 1. The primer probe sequence for detecting Urea Balloon in Comparative Example 1 is shown in Table 5 below.
[0080] Table 5 Primer probe sequences for detecting Ureaplasma
[0081]
[0082] The results of detecting Ureaplasma urea using the primers and probes in Example 1 (SEQ ID NOs: 1 to 3) and the primers and probes in Comparative Example 1 (SEQ ID NOs: 16 to 18) are as follows: Fig.13 The results of using the primers and probes (SEQ ID NOs: 16-18) in Comparative Example 1 to replace the primers and probes (SEQ ID NOs: 1-3) in Example 1 and combining them with the primers and probes (SEQ ID NOs: 4-15) in Example 1 to form a composition (SEQ ID NOs: 4-18) for joint testing of Ureaplasma urea, Bacillus sanguineus, Virido, Providencia stuartii and Providencia rettgeri are as follows: Fig.14 shown.
[0083] Fig.13 The amplification curves of the primers and probes (SEQ ID NOs: 1-3) in Example 1 and the primers and probes (SEQ ID NOs: 16-18) in Comparative Example 1 are used to detect Ureaplasma urea. Fig.13 It can be seen that the primers and probes for detecting Ureaballon used in Comparative Example 1 (SEQ ID NOs: 16-18) and the primers and probes for detecting Ureaballon used in Example 1 (SEQ ID NOs: 1-3) have good and comparable effects in detecting Ureaballon in a single detection system. Fig.14 The amplification curve of the combined test of Urea Balloon, Sanguinea Balloon, Green Balloon, Providencia stuartii and Providencia rettgeri in Comparative Example 1 is shown in FIG. Fig.14It can be seen that the composition for detecting urinary tract infection pathogens in comparative example 1 (primer probe sequence SEQ ID NO: 4-18) jointly detects 5 urinary tract infection pathogens (Urea Balloon, Blood Balloon, Green Balloon, Providencia stuartii and Providencia rettgeri), but the detection is affected in the five-joint detection system (SEQ ID NO: 4-18), and there is a significant reduction in detection performance, and even affects the detection of other targets. The amplification curves of Urea Balloon, Blood Balloon, Providencia stuartii and Providencia rettgeri do not show a typical "S type", and the Ct value of Green Balloon is 28.84, which is 1.83Ct value behind the Ct value of Green Balloon in the joint detection of Example 1, and the fluorescence increment of each urinary tract infection pathogen is reduced, the amplification curve increment is low, the sensitivity is low, the upstream primers, downstream primers and corresponding probes corresponding to each urinary tract infection pathogen have a large mutual influence, and the overall detection effect is poor. This fully demonstrates the superiority of the composition for detecting urinary tract infection pathogens of the present invention in the joint detection of Ureaplasma urea, Bacillus sanguineus, Gastroenteritis viridans, Providencia stuartii and Providencia rettgeri, and the mutual interference between different primers and probes is small.
[0084] The above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.
Claims
1. A composition for detecting pathogens of urinary tract infection, characterized in that: The composition comprises at least one of component A, component B, component C, component D, and component E; The component A comprises: a primer pair of SEQ ID NOs: 1 to 2, and a probe of SEQ ID NO: 3; the component A detects Ureaplasma; The component B comprises: a primer pair of SEQ ID NOs: 4 to 5, and a probe of SEQ ID NO: 6; the component B detects blood balloon bacteria; The component C comprises: a primer pair of SEQ ID NOs: 7 to 8, and a probe of SEQ ID NO: 9; the component C detects green balloon fungi; The component D comprises: a primer pair of SEQ ID NOs: 10 to 11, and a probe of SEQ ID NO: 12; the component D detects Providencia stuartii; The component E comprises: a primer pair of SEQ ID NOs: 13-14, and a probe of SEQ ID NO: 15; the component E detects Providencia rettgeri.
2. The composition for detecting urinary tract infection pathogens according to claim 1, characterized in that: The composition includes the component A, the component B, the component C, the component D and the component E.
3. The composition for detecting urinary tract infection pathogens according to claim 2, characterized in that: The probes in the component A, the component B, the component C, the component D and the component E are all labeled with fluorescent reporter groups, which are different from each other and do not interfere with each other.
4. The composition for detecting urinary tract infection pathogens according to claim 3, characterized in that: The fluorescent reporter group includes one of FAM, HEX, ROX, CY5 or Quasar 705.
5. A kit for detecting pathogens of urinary tract infection, characterized in that: The kit comprises the composition for detecting urinary tract infection pathogens according to any one of claims 1 to 4.
6. The kit for detecting urinary tract infection pathogens according to claim 5, characterized in that: In each reaction system, the concentration of each primer pair is 0.05 μM to 1 μM, and the concentration of each probe is 0.05 μM to 1 μM.
7. The kit for detecting urinary tract infection pathogens according to claim 5, characterized in that: The kit also includes a nucleic acid release reagent, a nucleic acid extraction reagent, a DNA polymerase, a UNG enzyme, a ribonuclease inhibitor, dNTP (U) s, a PCR buffer and Mg 2+ At least one of .
8. The kit for detecting urinary tract infection pathogens according to claim 7, characterized in that: In each reaction system, the concentration of the DNA polymerase is 0.1U / μL to 1U / μL, Mg 2+ The concentration of is 1mM~25mM, and the concentration of dNTP(U)s is 0.02mM~1mM.
9. The kit for detecting pathogens of urinary tract infection according to claim 5, characterized in that: The kit for detecting urinary tract infection pathogens also includes at least one of a positive quality control product and a negative quality control product.
10. A method for detecting pathogens of urinary tract infection for non-diagnostic purposes, characterized in that: The steps include: S1. Extracting nucleic acid from a sample to be tested to obtain a nucleic acid sample; S2. Performing PCR amplification on the nucleic acid sample using the kit for detecting urinary tract infection pathogens according to any one of claims 5 to 9; S3. Obtain and analyze the results.
